Syndax Pharmaceuticals (SNDX) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, to be held virtually at 12:00 P.M. EDT.

• Shareholders can access proxy materials and vote online or request paper copies.

• Board recommends voting FOR all director nominees and proposals listed.

Voting matters and shareholder proposals

• Election of two directors: Pierre Legault and Michael A. Metzger.

• Advisory vote to approve executive compensation as disclosed in the 2026 proxy statement.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.

• Approval of the 2026 Equity Incentive Plan.

• Approval of the 2026 Employee Stock Purchase Plan.

Board of directors and corporate governance

• Board recommends a vote FOR each director nominee and all proposals.